Effects of oleamide on choline acetyltransferase and cognitive activities

Bioscience, Biotechnology and Biochemistry

Volumn 67, Issue 6, 2003, Pages 1284-1291

  Heo, Ho Jin ^a,b,c,d,e   Park, Young June ^a,b,c,d,e   Suh, Young Min ^a,b,c,d,e   Choi, Soo Jung ^a,b,c,d,e   Kim, Mi Jeong ^a,b,c,d,e   Cho, Hong Yon ^a,b,c,d,e   Chang, Yun Jeong ^a,b,c,d,e   Hong, Bumshik ^a,b,c,d,e   Kim, Hye Kyung ^a,b,c,d,e   Kim, Eunki ^a,b,c,d,e   Kim, Chang Ju ^a,b,c,d,e   Kim, Byung Gee ^a,b,c,d,e   Shin, Dong Hoon ^a,b,c,d,e  

^a Korea University   (South Korea)

^b Hanseo University   (South Korea)

^c Inha University   (South Korea)

^d Kyung Hee University   (South Korea)

^e Seoul National University   (South Korea)

Author keywords

Alzheimer s disease; Choline acetyltransferase; Cognitive impairment; Oleamide; Zizyphus jujuba

Indexed keywords

CHOLINE ACETYLTRANSFERASE; OLEIC ACID; OLEYLAMIDE; PLANT EXTRACT; SCOPOLAMINE;

AMNESIA; ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; COGNITION; DRUG EFFECT; ENZYME ACTIVATION; FRACTIONATION; FRUIT; HUMAN; ISOLATION AND PURIFICATION; JUJUBE; MEDICINAL PLANT; MOUSE; TUMOR CELL LINE;

AMNESIA; ANIMALS; CELL LINE, TUMOR; CHEMICAL FRACTIONATION; CHOLINE O-ACETYLTRANSFERASE; COGNITION; ENZYME ACTIVATION; FRUIT; HUMANS; MICE; OLEIC ACIDS; PLANT EXTRACTS; PLANTS, MEDICINAL; SCOPOLAMINE; ZIZIPHUS;

ZIZIPHUS;

EID: 2142805799     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.67.1284     Document Type: Article

References (23)

1. Carr, D. B., Goate, A., and Morris, J. C., Current concepts in the pathogenesis of Alzheimer’s disease. Am. J. Med., 103, 3S-10S (1997).
2. Bird, T. D., Stranhan, S., Sumi, S. M., and Raskind, M., Alzheimer’s disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups. Ann. Neurol., 14, 284-293 (1983).
3. Gasparin, L., Rasshi, M., Binetti, G., Trabucchi, M., Solerte, S. B., Alkon, D., Etcheberrigary, R., Gibson, G., Blass, J., Paoletti, R., and Govoin, S., Peripheral markers in testing pathophysiological hypothesis and diagnosing Alzheimer’s disease. FASEB J., 12, 17-34 (1998).
4. Oda, Y., Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system. Pathol. Int., 49, 921-937 (1999).
5. Benishin, C. G., and Carroll, P. T., Acetylation of choline and homocholine by membrane bound choline-O-acetyltransferase endings. J. Neurochem., 36, 732-740 (1981).
6. Zambrzycka, A., Alberghina, M., and Strosznajder, J. B., Effects of aging and amyloid-b peptides on choline acetyltransferase activity in rat brain. Neurochem. Res., 27, 277-281 (2002).
7. Biedler, J. L., Roffler-Tarlov, S., Schachner, M., and Freedman, L. S., Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res., 38, 3751-3757 (1978).
8. Fonnum, F., A rapid radiometric method for the determination of choline acetyltransferase. J. Neurochem., 24, 407-409 (1975).
9. Rieger, F., Shelanski, M. L., and Greene, L. A., The effects of nerve growth factor on acetylcholinesterase and its multiple forms in cultures of rat PC12 pheochromocytoma cells: Increased total specific activity and appearance of the 16S molecular form. Dev. Biol., 76, 238-243 (1980).
10. Sarter, M., Bodewitz, G., and Stephens, D. N., Attenuation of scopolamine-induced impairment of spontaneous alternation behavior by antagonist but not inverse agonist and beta-carbolines. Psychopharmacology, 94, 491-495 (1988).
11. Bisogno, T., Sepe, N., Petrocellis, L. D., Mechoulam, R., and Marzo, V. D., The sleep inducing factor oleamide is produced by mouse neuroblastoma cells. Biochem. Biophys. Res. Commun., 239, 473-479 (1997).
12. Collerton, D., Cholinergic function and intellectual decline in Alzheimer’s disease. Neuroscience, 19, 1-28 (1986).
13. Park, C. H., Kim, S. H., Choi, W., Lee, Y. J., Kim, J. S., Kang, S. S., and Suh, Y. H., Novel acetylcholinesterase and antiamnesic activities of de-hydroevodiamine, a constituent of Evodia rutaecar-pa. Planta Med., 62, 405-409 (1996).
14. Cravatt, B. F., Prospero-Garcia, O., Siuzdak, G., Gillula, N. B., Henriksen, S. J., Boger, D. L., and Lerner, R. A., A gas chromatographic-mass spectral assay for the quantitative determination of oleamide in biological fluids. Science, 268, 1506-1509 (1995).
15. Resendiz-Huitron, S., Gombart, L., Cravatt, B. F., and Henriksen, S. J., Effect of oleamide on sleep and its relationship to blood pressure, body temperature and locomotor activity in rats. Exp. Neurol., 172, 235-243 (2001).
16. Broadwell, R. D., and Sofroniew, M. V., Serum proteins bypass the blood-brain fluid barriers for extracellular entry to the central nervous system. Exp. Neurol., 120, 245-263 (1993).
17. Glenner, G. G., and Wong, C. W., Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Proc. Natl. Acad. Sci. U.S.A., 92, 10739-10741 (1984).
18. Heo, H. J., Cho, H. Y., Hong, B. S., Kim, H. K., Kim, E. K., and Shin, D. H., Protective effect of 4?,5-dihydroxy-3?,6,7-trimethoxyflavone from Artemisia asiatica against Ab-induced oxidative stress in PC12 cells. Amyloid, 8, 194-201 (2001).
19. Behl, C., Alzheimer’s disease and oxidative stress: implications for novel therapeutic approaches. Prog. Neurobiol., 57, 301-323 (1999).
20. Maurice, T., Lockhart, B. P., and Privat, A., Amnesia induced in mice by centrally administered b-amyloid peptides involves cholinergic dysfunction. Brain Res., 706, 181-193 (1996).
21. Flood, J. F., Morley, J. E., and Roberts, E., Amnestic effects in mice of four synthetic peptides homologous to amyloid b protein from patients with Alzheimer’s disease. Proc. Natl. Acad. Sci. U.S.A., 88, 3363-3366 (1991).
22. Nitta, A., Itoh, A., Hasegawa, T., and Nabeshima, T., b-Amyloid protein-induced Alzheimer’s disease animal model. Neurosci. Lett., 170, 63-66 (1994).
23. Yamada, K., Tanaka, T., Han, D., Senzaki, K., Kameyama, T., and Nabeshima, T., Protective effects of idebenone and a-tocopherol on b-amyloid-(1-42)-induced learning and memory deficits in rats: implication of oxidative stress in b-amyloid-induced neurotoxicity in vivo. Eur. J. Neurosci., 11, 83-90 (1999).